No Data
No Data
Life Science Virtual Investor Forum Presentations Now Available for Online Viewing
Express News | Bone Biologics Shares Are Trading Lower. The Company Announced That the First Two Patients Have Been Treated in the Multicenter, Prospective, Randomized Pilot Clinical Study of the Company's NB1 Bone Graft Device
Express News | Watching Bone Biologics; Zacks Small-Cap Research Sets $19.50 Valuation
Express News | Bone Biologics Announces First Two Patients Treated In Pilot Clinical Study Of NB1 Bone Graft Device; NB1 Combines NELL-1 Protein With Demineralized Bone Matrix For Enhanced Bone Regeneration
First Two Patients Treated in Pilot Clinical Study With Bone Biologics' NB1 Bone Graft Device in Spine Fusion
Life Sciences Virtual Investor Forum Agenda Announced for June 20th
No Data
夜雨声烦 : I love someone with a sensitive sense of smell like you
FattyChickOP 夜雨声烦: Don't be bad bad